HomeDirector Liability in United States: When Personal Exposure Arises in Corporate Distress

Director Liability in United States: When Personal Exposure Arises in Corporate Distress

A board of directors approves a financing round, defers a creditor payment, and authorises a dividend – all within the same quarter. Months later, the company files for bankruptcy. Creditors sue the directors personally. That sequence, once considered exceptional, now appears with regularity before US federal and state courts. For international executives serving on US boards, the personal exposure embedded in American corporate distress law is neither theoretical nor distant.

Director liability in the United States arises when individual board members breach fiduciary duties owed to the corporation, its shareholders, or – in conditions of financial distress – its creditors. The primary legal doctrines are the duty of care, the duty of loyalty, and the duty of oversight, each grounded in state corporate legislation and refined by decades of court decisions, most authoritatively in Delaware. When a company enters the zone of insolvency, these duties expand in scope and the consequences of breach shift from corporate to personal.

This analysis examines the doctrinal foundations of director liability in the United States, the divergence between statutory text and court practice. The specific pressure points that arise during corporate distress. Additionally, the strategic steps directors. particularly those with cross-border exposure. should consider before and during financial difficulty.

Doctrinal foundations: fiduciary duties and their limits

US corporate legislation is primarily state law. Delaware dominates: the majority of large US corporations are incorporated there, and its Court of Chancery (Delaware's specialist corporate court) has produced the most developed body of director liability doctrine in the country. Other states follow similar principles, though the details differ.

Three duties form the core of director liability exposure. The duty of care requires directors to act on an informed basis, in good faith, and in a manner they reasonably believe serves the corporation's best interests. The duty of loyalty prohibits directors from placing personal interests above those of the corporation. The duty of oversight – derived from what practitioners often call the Caremark standard – requires directors to establish and monitor compliance systems sufficient to detect legal violations before they cause harm.

The business judgment rule sits alongside these duties as a protective doctrine. Courts applying it presume that directors who act on an informed basis, in good faith, and without personal conflict made a valid business decision. The rule is not absolute. It does not apply when directors are conflicted, when they act in bad faith, or when they fail to inform themselves adequately before deciding. A director who rubber-stamps management proposals without independent review, or who absents themselves from critical board meetings, may find the rule unavailable.

Critically, the articles of association – or certificate of incorporation, in US terminology – can include exculpation provisions that limit director liability for duty-of-care breaches. Delaware corporate legislation expressly permits such provisions. They do not, however, shield directors from liability for duty-of-loyalty breaches, intentional misconduct, or unlawful distributions. This distinction matters enormously in distress scenarios, where creditors typically challenge dividends and asset transfers as improper.

The composition of the board of directors itself affects the liability analysis. Outside directors with no management role have generally received more deference from courts than executive directors who are also officers. But outside status is not a shield. The duty of oversight applies equally, and courts have repeatedly held that even non-executive directors must actively engage with financial reporting, audit findings, and red flags raised by management or auditors.

The zone of insolvency: when creditor duties emerge

The most consequential shift in director liability occurs when a corporation approaches or enters insolvency. Under settled US corporate legislation and insolvency law, this transition fundamentally alters the director's duty landscape.

In a solvent corporation, directors owe fiduciary duties to the corporation for the benefit of its shareholders. When the company becomes insolvent – or enters what courts call the zone of insolvency – creditors acquire a stake in director conduct. The practical consequence is that transactions benefiting shareholders at creditor expense become directly challengeable. A dividend paid when the company could not meet its obligations, a management bonus approved weeks before a bankruptcy filing. Alternatively. An asset sale to a related party below market value. each of these can form the basis of personal liability claims against the approving directors.

The precise boundaries of the zone of insolvency remain contested. Courts in different US jurisdictions apply varying tests. Balance-sheet insolvency – liabilities exceeding assets – is one recognised standard. Cash-flow insolvency – inability to pay debts as they fall due – is another. Some courts require both. Others apply a forward-looking test: would a reasonable director have foreseen insolvency as a probable outcome of the decisions being made? The uncertainty is deliberate. It compels directors to seek professional advice early rather than waiting for a formal insolvency threshold to be crossed.

The doctrine of deepening insolvency adds a further layer of exposure. Under this theory, directors who allow a company to continue incurring debt after insolvency becomes apparent may be personally liable for the additional harm caused to creditors by prolonging the company's distressed existence. Not all jurisdictions accept deepening insolvency as an independent cause of action, and courts are divided on its scope. But the concept signals the broader principle: delay in responding to financial distress has direct legal consequences for the individuals responsible for governance.

For international executives – particularly those from civil law systems accustomed to clearer statutory thresholds – the US zone-of-insolvency doctrine can be disorienting. There is no single statutory trigger. The duty arises through case law, and its application is fact-specific. A director cannot assume that because the company has not formally filed for insolvency, the expanded creditor duties have not yet attached.

To discuss how US insolvency and corporate distress law applies to your board position, contact us at info@ferrazwhitmore.com.

Gap between statute and practice: what courts actually demand

The divergence between the statutory text of US corporate legislation and what courts expect in practice is wider than most international directors anticipate. Three areas illustrate the gap most clearly.

Board minutes and documentation. Corporate legislation in most US states requires that board decisions be recorded. In practice, courts scrutinise board minutes in distress litigation far more intensively than the statutory requirement suggests. Minutes that merely record outcomes – without reflecting the deliberation process, the information reviewed, and the questions raised – provide limited protection. A director who approved a contested transaction but cannot demonstrate through contemporaneous records that they considered alternatives, obtained independent advice, and weighed creditor interests may struggle to rely on the business judgment rule. The gap between "minutes were taken" and "the decision-making process was adequately documented" is where personal liability most often materialises.

Delegation and reliance on management. Directors are permitted to rely on management reports, financial statements, and expert opinions. Corporate legislation codifies this reliance right. But courts have held that blind reliance – accepting management representations without asking obvious follow-up questions in the face of known warning signs – falls short of the duty of care. A director who receives an audit report flagging material weaknesses in financial controls, takes no further action, and later approves a significant distribution cannot simply point to the statutory reliance right. Courts expect active engagement, not passive receipt of information.

Conflict transactions and the entire fairness standard. When a director has a personal interest in a transaction. or when a controlling shareholder is on the other side. the business judgment rule gives way to the entire fairness standard. Under entire fairness review, the court examines both the process by which the transaction was approved and the substance of its terms. This is a materially more demanding standard. Directors in conflicted transactions who fail to establish an independent committee, obtain a fairness opinion, or otherwise demonstrate arm's-length dealing face significant exposure even if the transaction was ultimately commercially reasonable.

The SEC (Securities and Exchange Commission) adds a further layer for directors of public companies. Disclosure obligations under federal securities legislation mean that directors who were aware of material information not disclosed to the market. including the true state of the company's financial health. may face regulatory action in addition to civil liability. The US District Court system handles both private securities litigation and government enforcement. Directors of distressed public companies therefore face simultaneous exposure in state corporate courts and federal forums.

For international executives serving on US boards, this dual-track exposure. state fiduciary duties enforced in courts like the Delaware Court of Chancery. Additionally. Federal securities obligations enforced in US District Court. creates a complexity that has no precise equivalent in most civil law systems. A single decision can generate concurrent proceedings in two separate legal systems, each with its own discovery rules, standards of proof, and potential remedies.

International directors considering or currently holding US board seats may also wish to review our analysis of M&A transactions in the United States, where director conflicts and approval processes receive particularly close scrutiny.

Cross-border dimensions: exposure for international directors and Americas clients

For clients operating across the Americas. whether a Brazilian conglomerate with a US subsidiary, a Colombian fund with a Delaware LLC investment vehicle. Alternatively. A European holding company with US operating entities. director liability in US corporate distress carries specific cross-border implications that deserve separate treatment.

The first concerns jurisdiction. A foreign national who accepts a directorship in a US-incorporated entity submits to the personal jurisdiction of US courts for matters arising from that role. This is not theoretical. Courts have exercised jurisdiction over foreign directors in distress litigation, holding them personally liable under US corporate legislation regardless of where they are resident or domiciled. The registered office of the US entity and the state of incorporation determine which state's corporate law applies. A Delaware LLC carries Delaware law obligations for all directors, regardless of their nationality.

The second concerns the interaction between US insolvency law and foreign restructuring proceedings. When a US subsidiary of a foreign parent enters distress, directors may find themselves caught between competing obligations. US bankruptcy courts apply their own priority rules and avoidance powers. A transaction that was permissible – or even required – under the parent company's home jurisdiction law may constitute a voidable preference or fraudulent transfer under US insolvency legislation. Directors who authorised upstream payments, intercompany loans, or asset transfers in the period before a US filing face scrutiny under US law, not the law of their home country.

The third dimension is dispute resolution. Many US shareholder agreements and LLC operating agreements include arbitration clauses referring disputes to JAMS (Judicial Arbitration and Mediation Services) or the AAA (American Arbitration Association). Director liability claims brought under these clauses proceed through private arbitration rather than open court. This creates a parallel track to state court litigation. Directors should understand which forum governs their exposure before a dispute arises, and whether their indemnification rights under the corporate charter extend to arbitration proceedings.

For Latin American executives in particular, the contrast with home-jurisdiction practice can be significant. In several civil law systems across the Americas, director liability is more narrowly defined by statute and requires a higher threshold of fault. US law – especially in Delaware – is more interventionist. Courts are willing to examine board-level decision-making in granular detail. The volume of documentary discovery available to plaintiffs in US litigation is substantially greater than in most civil law jurisdictions. An executive accustomed to a civil law standard of review who serves on a US board without adjusting their governance practices accordingly assumes a level of risk they may not fully appreciate.

Our analysis of director liability in Brazil provides a useful comparison for clients managing board positions across both jurisdictions simultaneously.

Strategic recommendations: what directors should do before distress deepens

The most effective protection against personal liability in US corporate distress is preparation before the crisis becomes acute. The following considerations address the key inflection points where exposure typically crystallises.

Establish a monitoring baseline. Directors should ensure that board reporting includes regular financial health indicators – liquidity ratios, debt covenant compliance, accounts payable aging, and cash flow projections. These are not merely management tools. They serve as the evidentiary record of what the board knew, and when. A director who can demonstrate that they received and reviewed detailed financial reporting at each board meeting is in a materially stronger position than one who relied on summary presentations.

Identify the zone early. When financial indicators begin to deteriorate, directors should seek independent legal and financial advice before the company formally enters distress. The question of whether the company has crossed into the zone of insolvency is a legal judgment. It should not be left to management alone. An independent assessment – documented in board minutes – establishes that directors applied appropriate scrutiny at the right moment.

Scrutinise shareholder resolutions and distributions. Any shareholder resolution approving a dividend, a share buyback, or an intercompany transfer in a period of financial stress should be treated as high-risk from a director liability perspective. Courts have consistently held that distributions made when the company was balance-sheet or cash-flow insolvent are improper. Directors who approved such distributions face personal exposure for the amounts paid out. A solvency analysis, prepared by an independent adviser and recorded in the board minutes, is the minimum prudent step before approving any distribution in uncertain financial conditions.

Assess indemnification and D&O insurance. Most US corporations provide directors with indemnification rights under their corporate charter or LLC operating agreement. Directors should verify the scope of those rights, including whether they cover third-party claims, regulatory proceedings, and arbitration under JAMS or AAA rules. Directors and officers insurance policies provide a further layer of protection, but policy exclusions – particularly for fraud, wilful misconduct, and claims arising from insolvency – are common. Understanding coverage gaps before a claim arises allows directors to make informed decisions about the risk they are accepting.

Consider resignation carefully. Directors facing a distressed company sometimes consider resignation as a means of limiting exposure. This is not always effective. Under US corporate legislation and insolvency law, a director who resigns after becoming aware of a developing crisis may still be liable for decisions made during their tenure. Resignation does not retroactively cure a breach of duty. Moreover, a resignation that is not accompanied by proper notice and documentation can itself attract scrutiny. The decision to resign requires careful legal advice, not a reflexive response to discomfort.

Maintain independence in the boardroom. In distress situations, management and significant shareholders often have strong incentives to pursue strategies that benefit them at creditor expense. Directors must be willing to challenge those proposals, seek independent advice, and record dissenting views in the minutes. A director who defers entirely to management or to a controlling shareholder during a distress period loses the protections that independent conduct would otherwise provide.

To receive an expert assessment of your director liability exposure in the United States, contact us at info@ferrazwhitmore.com.

Regulatory trajectory and what to monitor

Director liability doctrine in the United States continues to evolve. Several developments merit close attention from international executives and their advisers.

Courts are increasingly willing to sustain duty-of-oversight claims – the so-called Caremark claims – that were historically difficult to pursue. For much of the past decade, courts dismissed these claims at the pleading stage, treating the bar for establishing a conscious disregard of oversight duties as exceptionally high. Recent decisions from the Delaware Court of Chancery signal a more receptive approach, particularly where directors failed to establish monitoring systems for specific, known legal risks relevant to the company's business. For companies in regulated industries – financial services, pharmaceuticals, technology – this shift is significant. Directors who cannot demonstrate that their boards actively monitored compliance in those specific risk areas face increased exposure.

Federal regulatory attention to director conduct in distressed companies has also intensified. The SEC has pursued enforcement actions against directors of public companies for failures to ensure accurate financial disclosure during periods of financial stress. These actions do not require proof of fraud. A pattern of disclosure failures, combined with evidence that directors were aware of the underlying financial deterioration, can support enforcement proceedings. Directors of US public companies should treat their disclosure obligations under federal securities legislation as a continuing, active responsibility – not a formality delegated entirely to management and outside counsel.

The treatment of environmental, social, and governance obligations is emerging as a further source of director liability risk. Corporate legislation in several US states is developing in ways that may impose affirmative duties on directors with respect to environmental compliance and stakeholder interests beyond shareholders. While this development is at an early stage and the doctrinal picture is unsettled, directors of companies with material environmental liabilities should monitor how courts and regulators treat these obligations in distress scenarios.

Finally, the role of alternative dispute resolution continues to expand. JAMS and AAA arbitration clauses are increasingly common in US shareholder agreements and investment documentation. As director liability claims migrate from open court to confidential arbitration, the body of publicly available precedent shrinks. Directors and their advisers must keep pace with arbitral practice as well as judicial decisions. The procedural rules of JAMS and AAA differ from court litigation in ways that affect discovery scope, hearing timelines, and available remedies – all of which influence the economics of a director liability dispute.

Frequently asked questions

Q: At what point does director liability shift from the corporation to individual directors during financial distress?

A: The shift typically occurs when a corporation reaches the zone of insolvency – a threshold recognised across US jurisdictions where creditor interests gain legal priority over shareholder interests. At that point, directors owe fiduciary duties not just to shareholders but, in many states, to creditors as well. The precise trigger varies by state corporate legislation, but deteriorating liquidity, inability to meet debt obligations, and deepening balance-sheet insolvency are the most commonly cited indicators.

Q: Does the business judgment rule protect directors who allow a company to continue trading while insolvent?

A: The business judgment rule offers meaningful protection when directors act on informed, good-faith decisions. However, it does not insulate directors who ignore clear warning signs of insolvency or who continue to incur debt without a credible recovery plan. Courts in Delaware and other states have held that passive inaction in the face of known financial deterioration can constitute a breach of the duty of oversight. Proactive steps – board minutes, independent financial assessments, and documented deliberations – are essential to preserving the protection.

Q: Can foreign nationals serving on a US company board face personal liability in federal court?

A: Yes. A foreign national who serves as a director of a US-incorporated entity – including a Delaware LLC or corporation – is subject to US corporate legislation and the jurisdiction of US federal and state courts. Personal liability can arise from fiduciary breaches, fraudulent transfers, or tax obligations regardless of the director's country of residence. Engaging a lawyer in the United States with cross-border experience is strongly advisable before accepting a board seat in a financially stressed US company.

About Ferraz & Whitmore

Ferraz & Whitmore is an international law firm based in Lisbon, advising business clients across 46 jurisdictions. Our team combines Portuguese civil law expertise with English common law tradition to deliver cross-border legal solutions in corporate governance, director liability, and corporate distress matters in the United States and across the Americas. We work with international entrepreneurs, institutional investors, and in-house legal teams who need results-oriented counsel across multiple legal systems. The firm's corporate law practice covers both common law and civil law jurisdictions. With experience advising directors on fiduciary duty exposure before courts including the US District Court system and in arbitration proceedings before JAMS and AAA. Our Lisbon base provides direct access to EU regulatory conditions, while our common law expertise supports enforcement and dispute strategies in US jurisdictions. As an international law firm serving clients who need a lawyer in the United States with cross-border competence, we help boards build effective governance structures before distress becomes crisis. To discuss your situation, contact us at info@ferrazwhitmore.com.

Disclaimer: This publication is provided for informational purposes only and does not constitute legal advice. The information herein should not be relied upon as a substitute for professional legal counsel tailored to your specific circumstances. Ferraz & Whitmore assumes no liability for actions taken or not taken based on the contents of this material. For advice regarding your particular situation, please contact info@ferrazwhitmore.com.